Viibryd Is the Latest Rx Med for Depression

Viibryd (VYE-brid, vilazodone) will be the latest antidepressant to hit pharmacy shelves.

Think of Viibryd as similar to Trintellix (vortioxetine). Both work similarly to increase serotonin levels in patients with depression.

Expect doses on Viibryd Rxs to "start low and go up slow" to help minimize stomach-related side effects. For instance, a patient may get 10 mg by mouth once daily for 7 days...followed by 20 mg daily for 7 days...then increased to the max dose of 40 mg daily, if needed.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote